Aspirin resistance: current status and role of tailored therapy
about
The association of four common polymorphisms from four candidate genes (COX-1, COX-2, ITGA2B, ITGA2) with aspirin insensitivity: a meta-analysisDiagnosing and managing diabetes in HIV-infected patients: current conceptsPlatelet content of nitric oxide synthase 3 phosphorylated at Serine 1177 is associated with the functional response of platelets to aspirin.No significant detectable anti-infection effects of aspirin and statins in chronic obstructive pulmonary diseaseDeterminants of reduced antiplatelet effect of aspirin in patients with stable coronary artery diseaseAspirin Resistance Predicts Adverse Cardiovascular Events in Patients with Symptomatic Peripheral Artery DiseaseOptimal aspirin dose in acute coronary syndromes: an emerging consensus.Prevalence of aspirin resistance in Asian-Indian patients with stable coronary artery disease.Antiplatelet treatment in the primary prophylaxis of cardiovascular disease in patients with arterial hypertension.Aspirin resistance in patients undergoing hemodialysis and effect of hemodialysis on aspirin resistance.Association of GPIa and COX-2 gene polymorphism with aspirin resistance.Antiplatelet effects of clopidogrel and aspirin after interventional patent foramen ovale/ atrium septum defect closure.Aspirin resistance and promoting blood circulation and removing blood stasis: current situation and prospectives
P2860
Q26860958-0987FD64-1FAA-4A57-8547-D558B5A9F1B2Q27014697-3ED9361F-C47E-4844-8D3A-59111BAF2EAEQ35077628-62146B88-8FA7-4E51-B710-B8A9DAC67F24Q35197476-C054DF48-69A3-48BC-84B1-5F6711E4307EQ35620590-33D9F213-298E-4778-AA2F-791DF513C895Q37527747-4BAD55C2-5720-4DEB-9EB3-1610BFF13743Q38206844-3E8CB521-3F91-4430-BE5E-E06EBF4B07E4Q40534523-00EC96B4-8013-44A1-B5C2-C7B08032CF89Q41076435-A2C04329-B6CA-45F8-AE21-BFC6DCCF3870Q44464550-971FC5E3-23D6-4871-A05F-35D9EB3F6129Q47628253-62B78A27-BB47-440A-99E7-83312943B920Q52903388-2A46027B-8D59-4D29-855E-D39462E33874Q59040294-CC09A1DA-0EE6-4112-9A38-F0EC7ADD0297
P2860
Aspirin resistance: current status and role of tailored therapy
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Aspirin resistance: current status and role of tailored therapy
@ast
Aspirin resistance: current status and role of tailored therapy
@en
Aspirin resistance: current status and role of tailored therapy
@nl
type
label
Aspirin resistance: current status and role of tailored therapy
@ast
Aspirin resistance: current status and role of tailored therapy
@en
Aspirin resistance: current status and role of tailored therapy
@nl
prefLabel
Aspirin resistance: current status and role of tailored therapy
@ast
Aspirin resistance: current status and role of tailored therapy
@en
Aspirin resistance: current status and role of tailored therapy
@nl
P2860
P356
P1433
P1476
Aspirin resistance: current status and role of tailored therapy
@en
P2093
Christopher P Cannon
Jonathan Grinstein
P2860
P304
P356
10.1002/CLC.22031
P407
P577
2012-11-01T00:00:00Z